serum
level
igg
igm
iga
sever
acut
respiratori
distress
syndrom
sar
associ
coronaviru
sarscov
detect
serial
use
immunofluoresc
antibodi
assay
patient
sar
seroconvers
igg
mean
day
occur
simultan
day
earlier
igm
iga
mean
day
igg
could
detect
earli
day
onset
ill
earliest
time
three
antibodi
reach
peak
level
similar
mean
day
high
igg
level
could
persist
month
kinet
neutralis
antibodi
obtain
tissu
cultur
infect
dose
tcid
sarscov
strain
five
patient
sar
nearli
parallel
igg
signific
differ
kinet
igg
igm
iga
respons
patient
without
underli
medic
diseas
steroid
intraven
immunoglobulin
therapi
mechan
ventil
sever
acut
respiratori
distress
syndrom
sar
emerg
infect
affect
patient
mani
countri
highli
contagi
infect
propens
spread
healthcar
worker
household
member
may
also
caus
outbreak
commun
juli
taiwan
declar
free
sar
world
health
organ
laboratoryconfirm
sar
case
report
patient
die
first
sar
patient
taiwan
identifi
nation
taiwan
univers
hospit
ntuh
februari
patient
sar
eventu
identifi
hospit
outbreak
among
patient
microbiolog
evid
infect
sarsassoci
coronaviru
sarscov
includ
posit
rtpcr
realtim
rtpcr
assay
respiratori
serum
sampl
patient
indirect
enzymelink
immunosorb
assay
elisa
reveal
igg
antibodi
sarscov
serum
sampl
collect
day
onset
fever
aim
studi
evalu
chronolog
evolut
igm
iga
igg
neutralis
nt
antibodi
follow
sarscov
infect
patient
treat
ntuh
epidem
sar
patient
serial
serum
sampl
preserv
includ
studi
sera
patient
sampl
patient
collect
day
month
onset
ill
defin
first
appear
fever
bodi
temperatur
patient
age
year
mean
year
four
patient
underli
diseas
name
diabet
mellitu
n
hypertens
n
chronic
hepat
b
viru
carriag
n
correspond
author
reprint
request
pr
hsueh
nation
taiwan
univers
hospit
nation
taiwan
univers
colleg
medicin
chungshan
south
road
taipei
taiwan
email
hsporen
hamcntuedutw
patient
previous
healthi
sputum
throat
swab
specimen
patient
posit
sarscov
rna
specif
antibodi
igg
igm
iga
sarscov
determin
two
differ
immunofluoresc
antibodi
ifa
assay
inhous
assay
use
wholecel
lysat
infect
vero
cell
antigen
commerci
kit
antisarscoviift
euroimmun
beck
germani
inhous
ifa
assay
spot
slide
prepar
appli
vero
cell
suspens
either
infect
noninfect
sarscov
strain
genbank
access
slide
dri
fix
aceton
conjug
use
goat
antihuman
igg
igm
iga
conjug
fluorescein
isothiocyan
organon
teknikacappel
turnhout
belgium
start
dilut
serum
specimen
inhous
ifa
euroimmun
kit
determin
igm
iga
antibodi
ifa
igg
antibodi
remov
patient
sera
immunosorpt
antihuman
igg
use
either
eurosorb
kit
euroimmun
commerci
ifa
assay
gullsorb
kit
meridian
bioscienc
cincinnati
oh
usa
inhous
assay
cutoff
valu
posit
result
inhous
ifa
commerci
ifa
kit
igg
antibodi
sarscov
also
measur
indirect
elisa
recombin
nucleocapsid
coat
antigen
tmb
gener
biolog
hsinchu
taiwan
cutoff
valu
posit
igg
result
elisa
control
compris
pair
sera
patient
communityacquir
pneumonia
seen
ntuh
octob
decemb
sera
hospitalis
patient
acut
respiratori
distress
syndrom
treat
hospit
ten
sera
ten
pregnant
women
obtain
routin
prelabour
checkup
control
sera
test
presenc
igg
igm
iga
three
method
describ
briefli
sera
five
patient
incub
min
dilut
twofold
cell
cultur
medium
modifi
eagl
medium
aliquot
dilut
sera
fourfold
ad
cell
cultur
medium
contain
tissu
cultur
infect
dose
tcid
sarscov
strain
microtitr
plate
incub
h
co
v
v
final
vero
cell
ml
ad
well
plate
plate
incub
day
co
v
v
examin
daili
cytopath
effect
day
highest
dilut
serum
complet
inhibit
tcid
sarscov
record
nt
titr
nt
assay
perform
triplic
neg
control
sera
healthi
volunt
control
sera
neg
igg
elisa
igg
igm
iga
ifa
time
requir
seroconvers
determin
two
ifa
assay
igg
igm
iga
two
ifa
assay
elisa
igg
nearli
ident
among
patient
fig
test
igg
igm
iga
neg
least
day
onset
ill
patient
fig
assay
three
specif
antibodi
posit
least
day
onset
ill
patient
seroconvers
igg
mean
day
occur
time
day
earlier
igm
iga
mean
day
time
requir
first
peak
level
three
antibodi
similar
mean
day
fig
highest
level
igg
igm
iga
respect
patient
posit
igg
day
one
patient
high
level
igg
day
onset
ill
level
igm
iga
start
declin
week
onset
ill
remain
low
level
week
onset
addit
treatment
ribavirin
use
patient
patient
receiv
intraven
methylprednisolon
day
mean
day
onset
ill
day
igg
respons
receiv
intraven
immunoglobulin
day
mean
day
onset
ill
nine
given
mechan
ventil
day
mean
day
onset
ill
follow
respiratori
failur
signific
differ
kinet
igg
igm
iga
respons
patient
without
underli
medic
diseas
steroid
intraven
immunoglobulin
therapi
mechan
ventil
howev
two
patient
earli
igg
seroconvers
respect
day
ill
start
corticosteroid
therapi
day
one
patient
igg
antibodi
day
ill
corticosteroid
therapi
start
nt
antibodi
appear
day
mean
increas
thereaft
peak
day
four
patient
nt
antibodi
titr
remain
month
onset
day
ill
result
studi
demonstr
five
import
point
first
although
previou
report
indic
specif
igg
detect
sar
patient
day
diseas
present
studi
show
clearli
igg
seroconvers
start
earli
day
onset
ill
second
contrast
profil
antibodi
respons
acut
viru
infect
previou
find
humor
immun
igg
igm
sar
simultan
earlier
igg
respons
sarscov
compar
igm
iga
observ
indic
detect
igm
iga
would
provid
earlier
evid
sarscov
infect
detect
igg
third
studi
show
presenc
low
level
igm
iga
day
onset
ill
although
previou
studi
show
disappear
igm
week
fourth
presenc
underli
diseas
diabet
mellitu
hypertens
chronic
hepat
b
viru
carriag
use
immunosuppress
immunomodulatori
agent
influenc
dynam
antibodi
respons
ie
time
requir
achiev
seroconvers
peak
antibodi
level
final
presenc
high
level
specif
igg
nt
antibodi
sarscov
late
convalesc
stage
least
month
onset
ill
suggest
passiv
immunis
convalesc
plasma
concentr
sarscov
igg
antibodi
recov
sar
patient
might
option
treatment
sar
reason
simultan
slightli
earlier
igg
respons
unclear
time
isotyp
detect
might
depend
test
employ
actual
time
igmtoigg
switch
theoret
happen
patient
true
primari
respons
sar
acceler
secondari
respons
one
possibl
patient
infect
sarscov
document
febril
episod
epidem
difficult
exclud
extrem
unlik
previou
studi
emerg
room
worker
reveal
similar
antibodi
subclass
respons
two
patient
mild
symptom
fever
bodi
temperatur
one
asymptomat
worker
altern
observ
could
reflect
low
sensit
ifa
assay
detect
igm
iga
known
detect
igm
iga
without
separ
igg
yield
higher
rate
falseposit
falseneg
result
present
studi
igg
absorb
detect
igm
iga
two
differ
ifa
assay
accordingli
sensit
igm
iga
assay
igg
absorpt
rather
biolog
host
respons
might
contribut
phenomenon
therefor
serolog
respons
sarscovinfect
patient
might
need
examin
use
sensit
method
differ
antigen
theoret
steroid
like
interfer
establish
immun
respons
initi
present
studi
observ
delay
primari
immun
respons
steroid
therapi
previou
observ
suggest
upsurg
igg
antibodi
sarscov
correl
clinic
worsen
pneumonia
howev
present
studi
patient
whose
pulmonari
condit
improv
corticosteroid
therapi
similar
igg
profil
patient
later
develop
respiratori
failur
necessit
ventil
support
overexuber
host
respons
well
immunopatholog
process
might
contribut
worsen
diseas
progress
lung
damag
indebt
mani
member
frontlin
medic
nurs
staff
laboratori
personnel
nation
taiwan
univers
hospit
manag
patient
thank
ds
chen
critic
review
construct
comment
manuscript
